694 related articles for article (PubMed ID: 20429631)
1. No differences in outcome between radical surgical treatment (enucleation) and stereotactic radiosurgery in patients with posterior uveal melanoma.
Furdova A; Slezak P; Chorvath M; Waczulikova I; Sramka M; Kralik G
Neoplasma; 2010; 57(4):377-81. PubMed ID: 20429631
[TBL] [Abstract][Full Text] [Related]
2. Ruthenium-106 plaque brachytherapy for thick posterior uveal melanomas.
Kaiserman N; Kaiserman I; Hendler K; Frenkel S; Pe'er J
Br J Ophthalmol; 2009 Sep; 93(9):1167-71. PubMed ID: 19570767
[TBL] [Abstract][Full Text] [Related]
3. Gamma-knife-based stereotactic radiosurgery for uveal melanoma.
Fakiris AJ; Lo SS; Henderson MA; Witt TC; Worth RM; Danis RP; Des Rosiers PM; Timmerman RD
Stereotact Funct Neurosurg; 2007; 85(2-3):106-12. PubMed ID: 17228176
[TBL] [Abstract][Full Text] [Related]
4. Iodine brachytherapy as an alternative to enucleation for large uveal melanomas.
Puusaari I; Heikkonen J; Summanen P; Tarkkanen A; Kivelä T
Ophthalmology; 2003 Nov; 110(11):2223-34. PubMed ID: 14597534
[TBL] [Abstract][Full Text] [Related]
5. Ruthenium brachytherapy for uveal melanoma, 1979-2003: survival and functional outcomes in the Swedish population.
Bergman L; Nilsson B; Lundell G; Lundell M; Seregard S
Ophthalmology; 2005 May; 112(5):834-40. PubMed ID: 15878063
[TBL] [Abstract][Full Text] [Related]
6. Long-term survival in choroidal and ciliary body melanoma after enucleation versus plaque radiation therapy.
Augsburger JJ; Corrêa ZM; Freire J; Brady LW
Ophthalmology; 1998 Sep; 105(9):1670-8. PubMed ID: 9754176
[TBL] [Abstract][Full Text] [Related]
7. Posterior uveal melanoma treated with I-125 brachytherapy or primary enucleation.
Krohn J; Monge OR; Skorpen TN; Mørk SJ; Dahl O
Eye (Lond); 2008 Nov; 22(11):1398-403. PubMed ID: 17585309
[TBL] [Abstract][Full Text] [Related]
8. Prognostic factors for survival after enucleation for choroidal and ciliary body melanomas.
Isager P; Ehlers N; Overgaard J
Acta Ophthalmol Scand; 2004 Oct; 82(5):517-25. PubMed ID: 15453846
[TBL] [Abstract][Full Text] [Related]
9. One-day session LINAC-based stereotactic radiosurgery of posterior uveal melanoma.
Furdova A; Strmen P; Waczulikova I; Chorvath M; Sramka M; Slezak P
Eur J Ophthalmol; 2012; 22(2):226-35. PubMed ID: 21534252
[TBL] [Abstract][Full Text] [Related]
10. [Preliminary results of radiosurgery for uveal melanoma].
Xiao JP; Xu GZ; Miao YJ; Wei WB; Hu SM; Tang X; Wang JZ; Wang GL
Zhonghua Zhong Liu Za Zhi; 2005 Apr; 27(4):241-4. PubMed ID: 15949429
[TBL] [Abstract][Full Text] [Related]
11. Survival, anatomic, and functional long-term results in choroidal and ciliary body melanoma after ruthenium brachytherapy (15 years' experience with beta-rays).
Rouberol F; Roy P; Kodjikian L; Gérard JP; Jean-Louis B; Grange JD
Am J Ophthalmol; 2004 May; 137(5):893-900. PubMed ID: 15126155
[TBL] [Abstract][Full Text] [Related]
12. Local tumor control, visual acuity, and survival after hypofractionated stereotactic photon radiotherapy of choroidal melanoma in 212 patients treated between 1997 and 2007.
Dunavoelgyi R; Dieckmann K; Gleiss A; Sacu S; Kircher K; Georgopoulos M; Georg D; Zehetmayer M; Poetter R
Int J Radiat Oncol Biol Phys; 2011 Sep; 81(1):199-205. PubMed ID: 20675066
[TBL] [Abstract][Full Text] [Related]
13. [Stereotactic radiosurgery using the Gamma Knife for large uveal melanomas].
Mueller AJ; Schaller U; Talies S; Horstmann GA; Wowra B; Kampik A
Ophthalmologe; 2003 Feb; 100(2):122-8. PubMed ID: 12589456
[TBL] [Abstract][Full Text] [Related]
14. Gamma knife radiosurgery for uveal melanoma: 12 years of experience.
Modorati G; Miserocchi E; Galli L; Picozzi P; Rama P
Br J Ophthalmol; 2009 Jan; 93(1):40-4. PubMed ID: 18757470
[TBL] [Abstract][Full Text] [Related]
15. Survival after proton-beam irradiation of uveal melanomas.
Kodjikian L; Roy P; Rouberol F; Garweg JG; Chauvel P; Manon L; Jean-Louis B; Little RE; Sasco AJ; Grange JD
Am J Ophthalmol; 2004 Jun; 137(6):1002-10. PubMed ID: 15183783
[TBL] [Abstract][Full Text] [Related]
16. Metastasis-free survival following treatment for uveal melanoma with either stereotactic radiosurgery or enucleation.
Cohen VM; Carter MJ; Kemeny A; Radatz M; Rennie IG
Acta Ophthalmol Scand; 2003 Aug; 81(4):383-8. PubMed ID: 12859266
[TBL] [Abstract][Full Text] [Related]
17. Routes of extraocular extension of uveal melanoma: risk factors and influence on survival probability.
Coupland SE; Campbell I; Damato B
Ophthalmology; 2008 Oct; 115(10):1778-85. PubMed ID: 18554722
[TBL] [Abstract][Full Text] [Related]
18. Stereotactic radiosurgical treatment in 103 patients for 153 cerebral melanoma metastases.
Selek U; Chang EL; Hassenbusch SJ; Shiu AS; Lang FF; Allen P; Weinberg J; Sawaya R; Maor MH
Int J Radiat Oncol Biol Phys; 2004 Jul; 59(4):1097-106. PubMed ID: 15234044
[TBL] [Abstract][Full Text] [Related]
19. Factors affecting the outcome after treatment for metastatic melanoma to the brain.
Carrubba CJ; Vitaz TW
Surg Neurol; 2009 Dec; 72(6):707-11. PubMed ID: 19604550
[TBL] [Abstract][Full Text] [Related]
20. Retrospective evaluation of patients with uveal melanoma treated by stereotactic radiosurgery with and without tumor resection.
Suesskind D; Scheiderbauer J; Buchgeister M; Partsch M; Budach W; Bartz-Schmidt KU; Ritz R; Grisanti S; Paulsen F
JAMA Ophthalmol; 2013 May; 131(5):630-7. PubMed ID: 23494018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
